ORA
Ormat Technologies, Inc. NYSE Listed Nov 11, 2004$122.31
Mkt Cap $7.5B
52w Low $70.42
83.5% of range
52w High $132.58
50d MA $111.07
200d MA $107.25
P/E (TTM)
55.6x
EV/EBITDA
17.3x
P/B
2.6x
Debt/Equity
1.1x
ROE
4.9%
P/FCF
-23.6x
RSI (14)
—
ATR (14)
—
Beta
0.80
50d MA
$111.07
200d MA
$107.25
Avg Volume
876.7K
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guadeloupe, Guatemala, Ethiopia, New Zealand, Honduras, and internationally. It operates through three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal, recovered energy-based electricity generation, and remote power units, such as fossil fuel powered turbo-generators and heavy duty direct-current generators; and provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. The Product segment serves contractors; developers, owners, and operators of geothermal power plants; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The Energy Storage segment offers energy storage and related services, as well as services relating to the engineering, procurement, construction, operation, and maintenance of energy storage units. Ormat Technologies, Inc. was founded in 1965 and is based in Reno, Nevada.
6140 Plumas Street · Reno, NV 89519-6075 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.92 | 1.30 | +41.3% | 114.86 | +7.0% | +6.7% | — | — | — | — | — |
| Feb 25, 2026 | AMC | 0.67 | 0.67 | +0.0% | 117.06 | -1.4% | -9.0% | -2.6% | +3.3% | -1.0% | +1.6% | — |
| Nov 3, 2025 | AMC | 0.37 | 0.41 | +10.8% | 107.82 | +4.1% | +0.8% | +4.8% | +0.8% | -1.1% | +0.9% | — |
| Aug 6, 2025 | AMC | 0.37 | 0.48 | +29.7% | 85.20 | -0.2% | +2.5% | -0.7% | +1.0% | +1.5% | +0.7% | — |
| May 7, 2025 | AMC | 0.58 | 0.68 | +17.2% | 72.31 | +5.4% | +2.5% | +1.0% | -1.0% | -0.9% | -0.5% | — |
| Feb 26, 2025 | AMC | 0.47 | 0.72 | +53.2% | 68.29 | +3.6% | +1.0% | +1.3% | -1.6% | +1.3% | -0.2% | — |
| Nov 6, 2024 | AMC | 0.31 | 0.42 | +35.5% | 81.92 | -0.4% | +1.4% | +0.1% | +0.9% | -5.2% | -0.4% | — |
| Aug 6, 2024 | AMC | 0.36 | 0.40 | +11.1% | 73.94 | +3.0% | -2.0% | +1.0% | -0.9% | -1.1% | +1.4% | — |
| May 8, 2024 | AMC | 0.63 | 0.64 | +1.6% | 68.49 | +3.1% | +0.6% | +2.0% | +0.5% | +3.6% | -0.1% | — |
| Feb 21, 2024 | AMC | 0.59 | 0.59 | +0.0% | 67.22 | -3.6% | -4.8% | +0.7% | -0.9% | +1.8% | -0.8% | — |
| Nov 8, 2023 | AMC | 0.35 | 0.59 | +68.6% | 62.42 | -1.8% | +0.2% | -2.8% | -2.9% | +8.9% | +1.3% | — |
| Aug 2, 2023 | AMC | 0.34 | 0.40 | +17.6% | 79.07 | +1.9% | -4.1% | +1.5% | +2.4% | -1.6% | -0.6% | — |
| May 9, 2023 | AMC | 0.50 | 0.51 | +2.0% | 85.21 | +0.3% | -2.1% | +0.2% | +0.4% | +0.4% | -0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 | JP Morgan | Maintains | Neutral → Neutral | — | $113.81 | $113.44 | -0.3% | -1.1% | +0.5% | -1.2% | -3.2% | -1.1% |
| Mar 3 | UBS | Maintains | Buy → Buy | — | $107.15 | $105.16 | -1.9% | -1.0% | +1.6% | +0.0% | +1.0% | +0.9% |
| Mar 2 | Barclays | Maintains | Overweight → Overweight | — | $103.70 | $104.59 | +0.9% | +3.3% | -1.0% | +1.6% | +0.0% | +1.0% |
| Feb 27 | Baird | Maintains | Outperform → Outperform | — | $106.47 | $105.58 | -0.8% | -2.6% | +3.3% | -1.0% | +1.6% | +0.0% |
| Feb 18 | Citigroup | Maintains | Neutral → Neutral | — | $124.22 | $123.07 | -0.9% | -2.6% | -0.8% | -3.4% | -0.6% | +0.6% |
| Feb 13 | Jefferies | Downgrade | Buy → Hold | — | $120.40 | $116.26 | -3.4% | -1.8% | +5.1% | -2.6% | -0.8% | -3.4% |
| Jan 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $123.59 | $124.05 | +0.4% | +2.1% | +1.4% | +0.0% | -2.4% | +0.7% |
| Jan 15 | Barclays | Maintains | Overweight → Overweight | — | $119.72 | $119.79 | +0.1% | -3.2% | +1.8% | -0.2% | +3.7% | +0.8% |
| Jan 9 | TD Cowen | Upgrade | Hold → Buy | — | $114.02 | $115.97 | +1.7% | +1.2% | +3.2% | +1.2% | -0.6% | -3.2% |
| Dec 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $108.84 | $111.35 | +2.3% | +1.4% | +0.4% | +1.2% | +1.1% | +0.9% |
| Nov 7 | UBS | Maintains | Buy → Buy | — | $114.75 | $113.30 | -1.3% | -1.1% | +0.9% | -1.5% | -1.3% | -3.1% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $114.75 | $113.30 | -1.3% | -1.1% | +0.9% | -1.5% | -1.3% | -3.1% |
| Nov 5 | JP Morgan | Maintains | Neutral → Neutral | — | $108.65 | $110.62 | +1.8% | +4.8% | +0.8% | -1.1% | +0.9% | -1.5% |
| Nov 5 | Roth Capital | Maintains | Buy → Buy | — | $108.65 | $110.62 | +1.8% | +4.8% | +0.8% | -1.1% | +0.9% | -1.5% |
| Nov 5 | TD Cowen | Maintains | Hold → Hold | — | $108.65 | $110.62 | +1.8% | +4.8% | +0.8% | -1.1% | +0.9% | -1.5% |
| Oct 16 | JP Morgan | Maintains | Neutral → Neutral | — | $109.21 | $109.88 | +0.6% | +1.1% | -1.6% | +1.1% | -4.0% | -1.3% |
| Oct 7 | Jefferies | Maintains | Buy → Buy | — | $104.13 | $103.97 | -0.2% | +0.7% | +2.0% | -0.3% | -2.5% | +3.2% |
| Sep 17 | Piper Sandler | Upgrade | Neutral → Overweight | — | $91.05 | $92.37 | +1.4% | +1.6% | +1.6% | -1.6% | +0.2% | +1.2% |
| Aug 19 | Piper Sandler | Maintains | Neutral → Neutral | — | $92.02 | $91.75 | -0.3% | +0.8% | -0.5% | +0.3% | +2.4% | -2.3% |
| Aug 8 | Barclays | Maintains | Overweight → Overweight | — | $87.33 | $87.61 | +0.3% | -0.7% | +1.0% | +1.5% | +0.7% | -1.3% |
| Aug 5 | Roth Capital | Maintains | Buy → Buy | — | $88.38 | $85.60 | -3.1% | -3.6% | -0.0% | +2.5% | -0.7% | +1.0% |
| Jul 30 | Baird | Upgrade | Neutral → Outperform | — | $88.15 | $89.03 | +1.0% | +1.5% | -0.0% | -0.8% | -0.4% | -3.6% |
| Jul 24 | UBS | Maintains | Buy → Buy | — | $90.41 | $88.97 | -1.6% | -1.5% | +0.4% | -1.2% | -0.3% | +1.5% |
| Jul 22 | JP Morgan | Maintains | Neutral → Neutral | — | $89.60 | $89.79 | +0.2% | +0.9% | +0.0% | -1.5% | +0.4% | -1.2% |
| Jul 10 | Barclays | Maintains | Overweight → Overweight | — | $88.14 | $87.02 | -1.3% | +0.5% | -0.8% | -0.4% | -0.9% | +0.8% |
| Jun 6 | Barclays | Upgrade | Equal Weight → Overweight | — | $75.12 | $77.00 | +2.5% | +3.5% | +0.1% | +1.5% | +0.9% | -0.7% |
| May 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $72.31 | $76.22 | +5.4% | +2.5% | +1.0% | -1.0% | -0.9% | -0.5% |
| Mar 25 | Jefferies | Maintains | Buy → Buy | — | $71.15 | $71.56 | +0.6% | +0.1% | -2.0% | +0.4% | +0.7% | +0.3% |
| Feb 28 | JP Morgan | Maintains | Neutral → Neutral | — | $68.94 | $69.58 | +0.9% | +1.3% | -1.6% | +1.3% | -0.2% | -0.1% |
| Feb 20 | Jefferies | Upgrade | Hold → Buy | — | $66.03 | $67.69 | +2.5% | +4.9% | -0.7% | -0.3% | -0.2% | -0.3% |
| Nov 8 | Roth MKM | Maintains | Buy → Buy | — | $83.05 | $82.80 | -0.3% | +0.1% | +0.9% | -5.2% | -0.4% | +0.3% |
| Nov 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $83.05 | $82.80 | -0.3% | +0.1% | +0.9% | -5.2% | -0.4% | +0.3% |
| Aug 12 | Roth MKM | Maintains | Buy → Buy | — | $72.51 | $71.24 | -1.8% | -1.1% | +1.4% | +0.0% | +1.3% | +0.1% |
| Aug 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.49 | $72.96 | +0.6% | +1.0% | -0.9% | -1.1% | +1.4% | +0.0% |
| Jul 16 | JP Morgan | Maintains | Neutral → Neutral | — | $72.96 | $73.18 | +0.3% | +4.2% | -0.8% | -0.5% | -1.5% | +1.7% |
| Jun 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $70.90 | $70.87 | -0.0% | +2.0% | +0.9% | +0.2% | -0.2% | +1.5% |
| May 14 | UBS | Maintains | Buy → Buy | — | $70.65 | $71.79 | +1.6% | +3.6% | -0.1% | -0.9% | +0.0% | -1.6% |
| May 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $70.29 | $70.57 | +0.4% | +0.5% | +3.6% | -0.1% | -0.9% | +0.0% |
| May 10 | TD Cowen | Maintains | Hold → Hold | — | $68.93 | $69.42 | +0.7% | +2.0% | +0.5% | +3.6% | -0.1% | -0.9% |
| Feb 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $65.55 | $64.42 | -1.7% | -2.0% | +2.1% | -0.1% | -2.2% | +1.6% |
| Jan 19 | Oppenheimer | Maintains | Outperform → Outperform | — | $66.69 | $66.75 | +0.1% | +0.0% | +1.0% | -1.3% | -1.5% | +1.3% |
| Oct 19 | JP Morgan | Maintains | Neutral → Neutral | — | $68.00 | $67.79 | -0.3% | -1.0% | -1.3% | -2.2% | -1.0% | -1.1% |
| Oct 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $68.87 | $67.84 | -1.5% | -3.0% | +0.7% | +1.5% | +0.5% | -0.8% |
| Aug 7 | Roth MKM | Upgrade | Neutral → Buy | — | $76.98 | $78.56 | +2.1% | +2.4% | -1.6% | -0.6% | +0.1% | -0.2% |
| Jun 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $80.61 | $80.53 | -0.1% | +0.0% | -1.0% | -0.1% | +0.9% | -0.5% |
| Jun 16 | Citigroup | Maintains | Neutral → Neutral | — | $86.44 | $87.22 | +0.9% | -1.2% | -1.1% | +0.3% | -0.9% | -2.8% |
| May 22 | Barclays | Maintains | Equal Weight → Equal Weight | — | $83.48 | $84.12 | +0.8% | +1.6% | -0.4% | +0.9% | -1.4% | +1.1% |
| May 11 | Oppenheimer | Maintains | Outperform → Outperform | — | $83.40 | $83.73 | +0.4% | +0.2% | +0.4% | +0.4% | -0.8% | +1.0% |
| May 11 | Roth MKM | Maintains | Neutral → Neutral | — | $83.40 | $83.73 | +0.4% | +0.2% | +0.4% | +0.4% | -0.8% | +1.0% |
| Mar 27 | Citigroup | Maintains | Neutral → Neutral | — | $80.98 | $82.37 | +1.7% | +3.1% | +0.1% | +1.0% | +0.3% | +0.1% |
No insider trades available.
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
ORA has secured non-dilutive debt financing through 2026, providing capital without equity dilution, though investors should monitor repayment capacity given the non-accreting structure.
Mar 23
8-K
Ormat Technologies, Inc. -- 8-K Filing
I cannot provide a meaningful analysis as the filing summary contains only signature blocks and contact information without disclosing the material event triggering the 8-K filing.
Feb 26
8-K · 7.01
! Medium
Ormat Technologies, Inc. -- 8-K 7.01: Regulation FD Disclosure
Ormat Technologies disclosed material information via press release, which investors should review in Exhibit 99.1 for details on company developments affecting ORA stock.
Feb 17
Data updated apr 26, 2026 5:47pm
· Source: massive.com